Product Program year 2020 Source: CMS Open Payments

Xience Sierra Coronary Stent System

Device Cardiac Arrhythmias and Heart Failure

Open in the dashboard

General payments

$188,593

5,262 payments

Research payments

$286,645

13 payments

Through program year 2020, $188,593 in general payments and $286,645 in research payments were reported against Xience Sierra Coronary Stent System (Cardiac Arrhythmias and Heart Failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 General $40,194 1,309
2020 Research $286,645 13
2019 General $148,399 3,953

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $188,593 5,262 payments
Top recipients General payments · program year 2020
  1. Aziz Maksoud Cardiovascular Disease · Wichita, KS $2,454 6% · 42 payments
  2. Bassem Chehab Cardiovascular Disease · Wichita, KS $2,247 6% · 37 payments
  3. Jeffrey Yourshaw Interventional Cardiology · High Point, NC $1,054 3% · 13 payments
  4. James Choi Interventional Cardiology · Dallas, TX $772 2% · 8 payments
  5. Jasvindar Singh Interventional Cardiology · Saint Louis, MO $591 1% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Interventional Cardiology Internal Medicine $22,232 56% · 267 practitioners
  2. Cardiovascular Disease Internal Medicine $14,985 38% · 152 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $834 2% · 15 practitioners
  4. Internal Medicine $663 2% · 10 practitioners
  5. Pediatrics $295 <1% · 5 practitioners

The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Texas $8,409 21% · 98 recipients
  2. New Jersey $5,955 15% · 39 recipients
  3. Kansas $5,722 14% · 13 recipients
  4. New York $3,463 9% · 38 recipients
  5. Missouri $1,823 5% · 10 recipients

The top 5 of 44 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

5,262 general · 13 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record